BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31856222)

  • 1. Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.
    Filho HRM; Bierrenbach ALS; Capuani MLD; Mendrone A; Benzaken AS; Machado SM; Saivish MV; Sabino EC; Witkin SS; Mendes-Corrêa MC
    PLoS One; 2019; 14(12):e0226566. PubMed ID: 31856222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality among blood donors seropositive and seronegative for Chagas disease (1996-2000) in São Paulo, Brazil: A death certificate linkage study.
    Capuani L; Bierrenbach AL; Alencar AP; Mendrone A; Ferreira JE; Custer B; Ribeiro ALP; Sabino EC
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005542. PubMed ID: 28545053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival analysis over a 20-year period of a Brazilian cohort of blood donors coinfected HIV-HCV.
    de Menezes Filho HR; Grandi G; Vaz Cardoso LP; Galvão da Silva JF; Machado SM; de Almeida-Neto C; Sabino EC; Mendes-Corrêa MC
    Braz J Infect Dis; 2023; 27(5):102810. PubMed ID: 37813358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy.
    Piselli P; Serraino D; Fusco M; Girardi E; Pirozzi A; Toffolutti F; Cimaglia C; Taborelli M;
    BMC Infect Dis; 2021 Jul; 21(1):667. PubMed ID: 34238231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.
    Guiltinan AM; Kaidarova Z; Custer B; Orland J; Strollo A; Cyrus S; Busch MP; Murphy EL
    Am J Epidemiol; 2008 Mar; 167(6):743-50. PubMed ID: 18203734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality among British Columbians testing for hepatitis C antibody.
    Yu A; Spinelli JJ; Cook DA; Buxton JA; Krajden M
    BMC Public Health; 2013 Apr; 13():291. PubMed ID: 23547940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Kovari H; Rauch A; Kouyos R; Rougemont M; Cavassini M; Schmid P; Stöckle M; Bernasconi E; Weber R; Ledergerber B;
    Clin Infect Dis; 2017 Feb; 64(4):490-497. PubMed ID: 28172403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.
    He Y; Zhang J; Zhong L; Chen X; Liu HM; Wan LK; Wang H; Li H; Tian L; Hu JL; Luo P; Wang L; Chen Y; Liu T; Liu SL; Lü WB
    J Med Virol; 2011 Apr; 83(4):616-21. PubMed ID: 21328375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.
    Rockstroh JK; Mocroft A; Soriano V; Tural C; Losso MH; Horban A; Kirk O; Phillips A; Ledergerber B; Lundgren J;
    J Infect Dis; 2005 Sep; 192(6):992-1002. PubMed ID: 16107951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors.
    Mandal AK; Kraus ES; Samaniego M; Rai R; Humphreys SL; Ratner LE; Maley WR; Burdick JF
    Clin Transplant; 2000 Aug; 14(4 Pt 2):391-6. PubMed ID: 10946777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India.
    Jain A; Rana SS; Chakravarty P; Gupta RK; Murthy NS; Nath MC; Gururaja S; Chaturvedi N; Verma U; Kar P
    Eur J Epidemiol; 2003; 18(7):695-7. PubMed ID: 12952145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease.
    Muñoz-Gómez R; García-Monzón C; García-Buey L; Lo Iacono O; Borque MJ; Garía-Sánchez A; Pajares JM; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):273-7. PubMed ID: 8724030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C infection in children who received extracorporeal membrane oxygenation.
    Nelson SP; Jonas MM
    J Pediatr Surg; 1996 May; 31(5):644-8. PubMed ID: 8861472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies.
    Alvarez-Muñoz MT; Vences-Aviles MA; Damacio L; Vázquez-Rosales G; Torres J; González-Bravo F; Muñoz O
    Arch Med Res; 2001; 32(5):442-5. PubMed ID: 11578761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.